Complete responses reported for Nkarta’s off-the-shelf NK cell therapies
On April 25, Nkarta, a biopharmaceutical company developing off-the-shelf engineered natural killer (NK) cell therapies, announced highly promising results from…
By
On April 25, Nkarta, a biopharmaceutical company developing off-the-shelf engineered natural killer (NK) cell therapies, announced highly promising results from…
ByPacritinib was found to be well-tolerated in the PRE-VENT trial with reduced number of grade 3+ events.
AzurRx BioPharma has started its Phase II clinical trial to evaluate micronised oral niclosamide tablets, known as FW-1022, in patients…
by William Newton in Texas. Kala Biopharmaceuticals’ ocular steroid Eysuvis (loteprednol etabonate) has a high probability of attaining the US…
ByThe US Food and Drug Administration (FDA) has approved the investigational new drug (IND) application of ARCA biopharma’s potential drug candidate AB201 (rNAPc2) to…
by Reynald Castaneda in London. Clover Biopharmaceuticals' Covid-19 protein subunit vaccine could potentially have the upper hand versus Novavax’s and IMV’s due to…
ByAccelerated Enrollment Solutions (AES) has launched new patient-transfer programme to assist biopharmaceutical companies amid coronavirus (Covid-19) pandemic.
Digital transformation solutions provider ALTEN Calsoft Labs has launched a new Blockchain clinical trial platform called BioPharma Ledger.